Curaleaf
Andrew Dancoe is an experienced professional in the field of analytical science and pharmaceutical chemistry, currently serving as Associate Director of the National Lab Platform at Curaleaf since February 2021. Andrew has held various roles at Curaleaf, including Senior Scientist and Process Development Scientist, contributing to analytical testing and pharmacokinetics while managing stability programs. Previous experience includes serving as Senior Analytical Scientist and Analytical Scientist at Ocean Spray Cranberries, focusing on quality control and research of cranberry products. Andrew's career began with roles at Lab Support and the University of Massachusetts Lowell, where significant research and teaching experience were acquired. Andrew also served honorably in the US Navy as a Hospital Corpsman, gaining leadership and clinical experience. Andrew holds a Master of Science in Pharmaceutical Sciences from the University of Florida and has two additional degrees in Biology.
This person is not in the org chart
This person is not in any teams
Curaleaf
42 followers
Curaleaf (CSE: CURA) is a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf is located in 10 states and owns and operates 26 dispensaries, 10 cultivation sites and 9 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York.